| Cat.No. |
Product Name |
Information |
Publication |
Customer Review |
| S2698 |
RS-127445 |
RS-127445 is a selective 5-HT2B antagonist with pKi of 9.5 and pIC50 of 10.4.
|
|
|
| S2691 |
BMY 7378 |
BMY 7378 is a multiple inhibitors of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively.
|
|
|
| S2663 |
WAY-100635 HCl |
WAY 100635 is a potent and selective 5-HT agonist with IC50 of 0.95 nM.
|
|
|
| S2677 |
BRL-15572 |
BRL-15572 is a 5-HT1D antagonist with pKi of 7.9.
|
|
|
| S2849 |
SB-269970 HCl |
SB-269970 HCl is a hydrochloride salt form of SB-269970, which is a 5-HT7 receptor antagonist with pKi of 8.3.
|
|
|
| S2875 |
Prucalopride |
Prucalopride is a selective, high affinity 5-HT receptor agonistfor 5-HT4a and 5-HT4b with Ki of 2.5 nM and 8 nM, respectively.
|
|
|
| S2894 |
SB-742457 |
SB-742457 is a highly selective 5-HT6 receptor antagonist with pKi of 9.63.
|
|
|
| S8021 |
Vortioxetine (Lu AA21004) hydrobromide |
Lu-AA21004 is an oral multimodal serotonergic agent, inhibits 5-HT(1A), 5-HT(1B), 5-HT(3A), 5-HT(7) and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
|
|
|
| S8010 |
PRX-08066 |
PRX-08066 is a selective 5-HT2B antagonist with IC50 of 3.4 nM.
|
|
|
| S2865 |
VUF 10166 |
VUF10166 is a novel, potent and competitive antagonist to 5-HT3A with Ki of 0.04 nM.
|
|
|
| S2856 |
SB 271046 |
SB-271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9.
|
|
|
| S2852 |
BRL 54443 |
BRL 54443 is a 5-HT1E and 5-HT1F receptor agonist with pKi of 8.7 and 9.25, respectively.
|
|
|
| S2669 |
LY310762 |
LY310762 is a 5-HT1D antagonist with Ki of ~0.2 μM.
|
|
|
| S2860 |
IEM 1754 Dihydrobromide |
IEM 1754 dihydrobroMide is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM.
|
|
|